127 related articles for article (PubMed ID: 21920249)
1. Subepidermal blistering disease with 3 distinct autoantibodies: anti-BP230, anti-laminin gamma-1, and anti-laminin-332.
Kikuchi K; Natsuga K; Shinkuma S; Nishie W; Kajita S; Sato H; Shimizu H
J Am Acad Dermatol; 2011 Oct; 65(4):878-880. PubMed ID: 21920249
[No Abstract] [Full Text] [Related]
2. Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen.
Chan LS; Lapiere JC; Chen M; Traczyk T; Mancini AJ; Paller AS; Woodley DT; Marinkovich MP
Arch Dermatol; 1999 May; 135(5):569-73. PubMed ID: 10328198
[TBL] [Abstract][Full Text] [Related]
3. Pemphigoid with autoantibodies to all laminin 332 subunits and BP230 developing vesicles within psoriatic plaques.
Ohata C; Mori Y; Tokita T; Koga H; Ohyama B; Sogame R; Hamada T; Ishii N; Furumura M; Hashimoto T
Eur J Dermatol; 2012; 22(6):812-3. PubMed ID: 23174568
[No Abstract] [Full Text] [Related]
4. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5.
Kawahara Y; Amagai M; Ohata Y; Ishii K; Hasegawa Y; Hsu R; Yee C; Yancey KB; Nishikawa T
J Am Acad Dermatol; 1998 Apr; 38(4):624-7. PubMed ID: 9555805
[No Abstract] [Full Text] [Related]
5. Blistering insights into the pathogenesis of bullous pemphigoid.
Wong HK; Bechtel MA
Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
[No Abstract] [Full Text] [Related]
6. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
7. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
[TBL] [Abstract][Full Text] [Related]
8. Refractory Pemphigoid with Autoantibodies to Both BP230 and Laminin gamma1.
Ashida H; Hamada T; Hosokawa Y; Hashimoto T; Nishie W; Ishii N; Nakama T; Kanno T; Ikeda M
Acta Derm Venereol; 2019 Nov; 99(12):1172-1173. PubMed ID: 31449311
[No Abstract] [Full Text] [Related]
9. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid.
Yamaki F; Mayuzumi N; Ikeda S; Hashimoto T
J Dermatol; 2010 Mar; 37(3):255-8. PubMed ID: 20507390
[TBL] [Abstract][Full Text] [Related]
11. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
13. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid.
Blöcker IM; Dähnrich C; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Zillikens D; Schmidt E
Br J Dermatol; 2012 May; 166(5):964-70. PubMed ID: 22242606
[TBL] [Abstract][Full Text] [Related]
15. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
16. Anti-laminin-332 mucous membrane pemphigoid with autoantibodies to α3, β3 and γ2 subunits of laminin-332 as well as to BP230 and periplakin associated with adenocarcinoma from an unknown primary site.
Fukuchi O; Suko A; Matsuzaki H; Baba H; Yoshida H; Takeuchi T; Odawara S; Fukuda S; Hashimoto T
J Dermatol; 2013 Jan; 40(1):61-2. PubMed ID: 22901273
[No Abstract] [Full Text] [Related]
17. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
18. BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?
Schmidt T; Sitaru C; Amber K; Hertl M
Br J Dermatol; 2014 Aug; 171(2):212-9. PubMed ID: 24601973
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
20. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
